Indication: Langerhans Cell Histiocytosis

International Collaborative Treatment Protocol For Children And Adolescents With Langerhans Cell Histiocytosis

Sub-indication: Langerhans Cell Histiocytosis

Interventional

Principal Investigator: Kerry K. McGowan, M.D.
Norton Children's Cancer Institute, affiliated with the UofL School of Medicine

Sponsor: North American Consortium for Histiocytosis

Search our entire site.